|
MechanismJAK3 gene inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismMAPKs inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Beijing Kexiang Zhongsheng Medical Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Kexiang Zhongsheng Medical Technology Co., Ltd.
100 Deals associated with Beijing Kexiang Zhongsheng Medical Technology Co., Ltd.
100 Translational Medicine associated with Beijing Kexiang Zhongsheng Medical Technology Co., Ltd.